Compared with corresponding normal tissues (Figure 1A), the expression of NEK6 are increased in breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), Lymphoid Neoplasm Diffuse Large B-cell Lymphoma, esophageal carcinoma (ESCA), Glioblastoma multiforme(GBM), HNSCC, kidney chromophobe (KICH), and Kidney renal papillary cell carcinoma (KIRP). This evidence concerns the gene NEK6 and head and neck squamous cell carcinoma.